Ngai, Lok Lam; Hanekamp, Diana; Janssen, Fleur; Carbaat-Ham, Jannemieke; Hofland, Maaike A M; Fayed, Mona M H E; Kelder, Angèle; Oudshoorn-van Marsbergen, Laura; Scholten, Willemijn J; Snel, Alexander N; Bachas, Costa; Tettero, Jesse M; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Griskevicius, Laimonas; Juliusson, Gunnar; van de Loosdrecht, Arjan A; Maertens, Johan A; Manz, Markus G; ... (2023). Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial. Blood, 141(21), pp. 2657-2661. American Society of Hematology 10.1182/blood.2022019160
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
blood.2022019160.pdf - Accepted Version Restricted to registered users only Available under License Publisher holds Copyright. Download (1MB) | Request a copy |
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Pabst, Thomas Niklaus |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1528-0020 |
Publisher: |
American Society of Hematology |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
18 Apr 2023 07:25 |
Last Modified: |
26 May 2023 00:15 |
Publisher DOI: |
10.1182/blood.2022019160 |
PubMed ID: |
36898087 |
BORIS DOI: |
10.48350/181793 |
URI: |
https://boris.unibe.ch/id/eprint/181793 |
Actions (login required)
 |
Edit item |